Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 10Recruiting 4Active not recruiting 4Unknown 3Terminated 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Tuberous Sclerosis 2Lennox Gastaut Syndrome 2Epilepsies, Myoclonic 2Seizures 1Neoplasms 1Liver Cirrhosis 1Anxiety Disorders 1

Interventions

pembrolizumab 439Carboplatin 323Nivolumab 291Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 254Paclitaxel 249Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 169atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Radiosurgery 114Oxaliplatin 114Pemetrexed 113Etoposide 111Fluorouracil 110venetoclax 108fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Cannabidiol × Clear all
NCT05485831 2026-06-03

EpiTALY

Jazz Pharmaceuticals

Active not recruiting
111 enrolled

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT05044819 2026-06-01

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Jazz Pharmaceuticals

Phase 4 Active not recruiting
154 enrolled

Epilepsies, Myoclonic, Liver Cirrhosis, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT05836857 2026-04-16

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

M.D. Anderson Cancer Center

Active not recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

NCT04482244 2025-07-29

RCT of CBD for Anxiety in Advanced Breast Cancer

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
60 enrolled 11 charts

Anxiety Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡